Drug treatment overviews on the availability of drug-related treatment are available for 30 countries — the 27 EU Member States, Norway as EMCDDA member, and Turkey and Croatia as Candidate Countries.
The drug treatment overviews consist of five main parts:
- description of the national context, i.e. overall drug treatment system and organisation;
- description of treatment registries and monitoring systems available in each country;
- current treatment demand data including new clients entering treatment for the first time and a breakdown by primary drug;
- availability and provision of treatment services in the country, with a specific focus on substitution treatment;
- references and additional resources.
The overviews are based primarily on data from standard tables on drug treatment and national reports. They have been developed with the assistance of the Reitox national focal points.